Eccema

Ajwain extract has shown anti-inflammatory effects in arthritis-induced rat models, improving inflammatory markers over 21 days. Thymol and carvacrol inhibit inflammatory pathways (COX, prostaglandins). Traditional Ayurvedic and Persian medicine also explicitly list rheumatoid arthritis as an indication.

A 2025 PMC review specifically analyzed AKG's mechanisms in osteoarthritis (OA), documenting its roles in autophagy regulation, gut microbiota modulation, cellular senescence reduction, and ferroptosis inhibition in chondrocytes. A 2026 MDPI review notes AKG restricts pro-inflammatory cytokine production and reduces cartilage degradation in arthritic models. Human clinical data in arthritis specifically are not yet published.

ALA reduces pro-inflammatory eicosanoids (LTB4, PGE2) that mediate joint inflammation and pain in arthritis. Animal studies and at least one placebo-controlled human trial support its anti-inflammatory benefit in arthritic conditions.

ALA has been studied in both osteoarthritis and rheumatoid arthritis (RA) in clinical trials. A trial in 78 osteoarthritis patients showed ALA significantly reduced serum TNF-α, IL-1β, IL-6, IL-17, and IL-23 and downregulated NF-κB. An RCT in 65 RA patients (8 weeks) and a further trial in 70 RA patients (1200 mg/day, 8 weeks) examined inflammatory and joint-damage biomarkers.

Omega-3 fatty acids including DHA from algal oil reduce joint inflammation and pain through anti-inflammatory mechanisms including suppression of pro-inflammatory cytokines. Clinical data from fish oil RCTs (directly applicable given algal oil bioequivalence) show reductions in joint stiffness and pain in inflammatory arthritis. Expert pharmacy guides recommend algal oil omega-3s as complementary to conventional arthritis treatment.

Aloe vera gel has been evaluated for osteoarthritis and inflammatory arthritis pain, showing anti-inflammatory activity via suppression of TNF-α and COX-2 gene expression in animal models. Oral aloe vera has been studied for chronic non-cancer pain including osteoarthritis. Traditional use in Ayurveda for arthritis pain is longstanding.

Animal studies demonstrate dose-dependent reduction in paw volume and arthritic scores with A. galanga extracts. In vitro, the extract downregulates MMP expression in human synovial fibroblasts. Traditional use for rheumatic pain is widely documented. Human RCT evidence is limited to a quasi-experimental study.

Andrographis paniculata contains andrographolide, which inhibits NF-κB and suppresses pro-inflammatory cytokines including IL-1β and TNF-α. A double-blind RCT (2009, Clinical Rheumatology) found a standardized Andrographis extract significantly reduced joint tenderness, swelling, and pain in rheumatoid arthritis patients compared to placebo.

Andrographolide is the primary bioactive diterpenoid from Andrographis paniculata that covalently inhibits NF-κB, suppressing pro-inflammatory mediators. A 2009 double-blind RCT (Clinical Rheumatology, n=60 RA patients) found andrographolide-standardized extract significantly reduced joint tenderness, swelling, and pain vs. placebo.

A human RCT of 100 knee osteoarthritis patients (30 mL/day argan oil for 8 weeks) demonstrated significant reductions in VAS pain scores, WOMAC index, and Lequesne index compared to controls, supporting argan oil's traditional Moroccan use for joint pain.

Several clinical trials support topical arnica for osteoarthritis of the knee and hand. An open multicenter trial (n=79) showed significant WOMAC score reductions at 3 and 6 weeks. A randomized double-blind trial (n=204) found arnica gel equivalent to ibuprofen 5% gel for hand osteoarthritis pain at 21 days. The German Commission E approves topical arnica for rheumatic joint pain.

Clinical trials and traditional Ayurvedic use support ashwagandha for both rheumatoid arthritis (RA) and osteoarthritis (OA). A prospective study in 86 RA patients showed significant reductions in joint tenderness, swelling, and ESR. A 12-week RCT in knee OA found significant pain reduction within 4 weeks. Withaferin A inhibits NF-κB and AP-1 pathways active in joint inflammation.

Astaxanthin's anti-inflammatory properties (inhibiting NF-κB, reducing IL-6, TNF-α, and COX-2) provide a mechanistic basis for arthritis benefit. Animal studies confirm reductions in joint inflammation and cartilage degradation markers. Human evidence is indirect, drawn from trials showing systemic anti-inflammatory effects; no dedicated human arthritis RCTs have been published.

Avocado-soybean unsaponifiables (ASU) are lipid extracts from avocado and soybean oils that inhibit pro-inflammatory cytokines, stimulate collagen synthesis, and block cartilage degradation. A Cochrane-referenced systematic review (PMC4494689) found moderate-quality evidence that ASU probably improved OA pain and function, and a 2017 meta-analysis (69 RCTs) rated ASU as having 'good evidence' for OA.

A double-blind, placebo-controlled RCT in RA patients (n=45) showed B. coagulans GBI-30, 6086 produced significant pain reduction and functional improvements as an adjunct to standard therapy. LAB probiotics including B. coagulans demonstrate immunomodulating and anti-inflammatory effects in both animal and human arthritis models.

Berberine from barberry has been referenced in clinical trial literature for osteoarthritis and rheumatoid arthritis. Experimental studies support anti-inflammatory and immunomodulatory mechanisms. Barberry's traditional use across Persian, Ayurvedic, and European medicine includes arthritis and joint inflammation.

Icariin has been studied for both osteoarthritis and rheumatoid arthritis in preclinical models, demonstrating cartilage-protective, anti-inflammatory, and chondrocyte-survival effects. The 2025 Frontiers in Pharmacology narrative review confirmed ICA's efficacy in bone and joint disease, including joint disorders. Traditional TCM uses include osteoarthritis and arthralgia.

Bovine collagen peptides have been studied in osteoarthritis RCTs and a meta-analysis, showing analgesic effects and reductions in knee joint pain during activity. Evidence is specifically for osteoarthritis (OA) rather than rheumatoid arthritis.

Betel leaf extract has demonstrated anti-arthritic and analgesic activity in animal models, including complete Freund adjuvant-induced arthritis in rats. Traditional use for joint pain in Malaysia and across Asia is well-documented. No human clinical trials currently exist.

An RCT in rheumatoid arthritis patients (500 mg/day N. sativa oil for 8 weeks, double-blind placebo-controlled) showed significant reduction in inflammatory cytokines and oxidative stress markers. Multiple clinical reviews categorise rheumatoid arthritis among the inflammatory and autoimmune conditions with clinical evidence for N. sativa.

Piperine inhibited IL-6, MMP13, COX-2, and PGE2 in human rheumatoid arthritis synoviocytes in vitro in a dose-dependent manner. In animal arthritis models it significantly reduced inflammation, nociception, and joint inflammatory area. A curcumin-piperine human RCT also documented antioxidant improvements in 40 osteoarthritis patients.

Anti-arthritic and antioxidant activity of A. scholaris leaf extracts has been evaluated in preclinical models, with the extract showing significant effects on WBC counts and erythrocyte sedimentation rate in arthritic groups. Traditional use includes topical application of bark paste and latex for rheumatic pain relief.

Clinical trials and a Cochrane systematic review provide scientific evidence for borage seed oil's benefit in inflammatory arthritis, particularly rheumatoid arthritis. GLA-derived DGLA suppresses synovial inflammation via eicosanoid modulation. Effect sizes in RCTs include reductions in tender joint counts and swelling.

The clinical evidence for borage oil in arthritis is concentrated in rheumatoid arthritis; several RCTs and a Cochrane review support GLA-containing oils including borage for reducing joint pain and disability. General (non-RA) inflammatory arthritis is extrapolated from the same GLA mechanism. Evidence for non-RA forms is indirect.

The NIH ODS states that observational evidence combined with small clinical studies suggests boron may reduce osteoarthritis symptoms, possibly by inhibiting inflammation. An Australian double-blind pilot RCT (6 mg/day, 8 weeks, n=20) found 50% of the boron-treated group improved versus 10% on placebo. Boron concentrations in bone and synovial fluid are lower in arthritis patients than in healthy controls.

Boswellia serrata resin extracts, standardized to boswellic acids, have been evaluated in multiple randomized controlled trials and a systematic meta-analysis for osteoarthritis and rheumatoid arthritis. The active constituent AKBA inhibits 5-lipoxygenase (5-LOX), suppressing leukotriene-mediated inflammation. A 2020 meta-analysis of seven RCTs (545 patients) found significant improvements in pain and joint function in knee OA.

Boswellic acids are the active triterpenic constituents of Boswellia serrata resin that inhibit 5-lipoxygenase, reducing leukotriene synthesis and joint inflammation. AKBA (3-acetyl-11-keto-β-boswellic acid) is the most potent isoform studied. Multiple RCTs and a meta-analysis confirm pain reduction and functional improvement in knee osteoarthritis.

A randomized controlled feasibility trial (BRIO study, 2024) specifically examined broccoli bioactives — particularly sulforaphane — in osteoarthritis patients. Human feeding studies show that broccoli consumption produces detectable sulforaphane in synovial fluid, the direct site of joint inflammation, supporting a mechanistically plausible therapeutic role.

Bromelain, a mixture of proteolytic enzymes from pineapple stem, has anti-inflammatory properties through fibrinolytic and cytokine-modulating mechanisms. It has been studied in combination and solo OA preparations, referenced in OA nutraceutical systematic reviews, and the Arthritis Foundation lists it among studied supplements for knee and hip OA.

A human clinical trial (Maghsoumi-Norouzabad et al., Int J Rheum Dis, 2016) demonstrated that daily burdock root tea for six weeks significantly reduced inflammatory markers (IL-6, hs-CRP) and improved antioxidant status in 36 knee osteoarthritis patients. A second trial from the same program showed improved lipid profile and blood pressure. Burdock has also shown anti-inflammatory and antinociceptive effects in validated experimental models.

Topical cabbage leaf wraps have been tested in RCTs for knee osteoarthritis and demonstrated significant pain reduction and improved function versus usual care. One RCT found cabbage leaf wraps outperformed diclofenac gel on pain scores. Oral cabbage's anti-inflammatory compounds (sulforaphane, anthocyanins) also have preclinical relevance to joint inflammation.

Cabbage leaf wraps for knee osteoarthritis have been tested in multiple randomized controlled trials. A 2016 RCT (Clinical Journal of Pain) found cabbage leaf wraps superior to usual care for pain, functional disability, and quality of life in knee OA patients. A 2022 RCT (Pain Research and Management, PMC) showed cabbage leaf application matched cooling gel pads and outperformed diclofenac gel on pain and Oxford Knee Score. Traditional European folk medicine also documents cabbage poultices for arthritic and rheumatic joints.

Marine omega-3s from sources including calamari oil have been used for both rheumatoid and osteoarthritis, with documented anti-inflammatory mechanisms that reduce joint swelling and pain. Clinical evidence is more consistent for RA than OA. DHA reduced knee edema and improved functional outcomes in preclinical arthritis models.

Campesterol has demonstrated antiarthritic activity in preclinical models through anti-inflammatory and analgesic mechanisms, reducing joint edema and cytokine production. The evidence base is primarily from CFA-induced rat arthritis models and systematic reviews of in vitro and in vivo studies. Clinical human trials are absent.

The PMC 2025 comprehensive review documents camphor's use in arthritis, noting it is readily absorbed topically and has been shown to ease joint inflammation. A 2018 review in Postgraduate Medicine assessed topical therapies for knee osteoarthritis including camphor-containing compounds. Traditional Korean medicine has prescribed camphor specifically for arthritis and rheumatism.

Capsaicin, the pungent vanilloid compound from chili peppers, depletes substance P from sensory nerve endings via TRPV1 receptor activation, reducing arthritic joint pain. Multiple RCTs and a systematic review meta-analysis confirm topical capsaicin reduces OA pain, with the Cochrane evidence base supporting its use for hand OA particularly.

Topical capsaicin cream is one of the most clinically validated natural treatments for osteoarthritis and rheumatoid arthritis. Multiple RCTs and systematic reviews with meta-analysis confirm significant pain reduction vs. placebo. Network meta-analysis shows efficacy comparable to topical NSAIDs for knee OA.

Topical capsaicin is a well-established, FDA-recognized analgesic for osteoarthritis pain, supported by multiple RCTs showing significant pain reduction via substance P depletion and epidermal nerve fiber density reduction. Evidence also exists for benefit in rheumatoid arthritis.

BCP has been studied in both osteoarthritis and collagen antibody-induced arthritis (CAIA) models, demonstrating significant reductions in joint inflammation, pro-inflammatory cytokines, and matrix metalloproteinases. Effects are confirmed CB2- and PPAR-γ-dependent.

Cat's Claw (Uncaria tomentosa), a woody vine from South America, contains oxindole alkaloids and pentacyclic triterpenes that inhibit TNF-α and NF-κB, mimicking the mechanism of biologic RA drugs. A 2002 double-blind RCT (Journal of Rheumatology) in 40 RA patients found Cat's Claw reduced joint swelling and pain by more than 50% versus placebo.

Topical capsaicin is supported by multiple RCTs and a positive meta-analysis for osteoarthritis pain relief. A systematic review and meta-analysis published in Phytotherapy Research (2024) confirmed topical capsaicin significantly reduces osteoarthritis pain. A 0.0125% gel was effective in a placebo-controlled trial of 100 patients over 4 weeks.

Anti-arthritic activity of A. aspera has been documented in preclinical studies. Gokhale et al. (2002) confirmed anti-arthritic and anti-inflammatory effects, and the activity is referenced across multiple peer-reviewed reviews.

Several RCTs have tested tart cherry juice in knee osteoarthritis. A double-blind crossover RCT (n=58) found that tart cherry juice significantly reduced hsCRP but did not surpass placebo on pain symptom scores. Smaller trials and observational studies report improvements in mobility and pain markers. Evidence for gout-type inflammatory arthritis is stronger.

A small pilot clinical trial tested chicory root extract in patients with osteoarthritis of the knee and hip, finding limited efficacy at the highest dose tested (1,800 mg/day) on validated symptom scales. Traditional use for rheumatic complaints and arthritis is extensively documented across multiple herbal traditions.

Danshen has been studied for osteoarthritis and rheumatoid arthritis within musculoskeletal disease research, with evidence showing its anti-inflammatory and cartilage-protective effects. Traditional use for 'rheumatism and joint pain' (arthralgia syndrome) is well-documented. Preclinical and some clinical trial data support its role in joint inflammation reduction.

Chondroitin sulfate is a glycosaminoglycan naturally occurring in articular cartilage. It has been studied in multiple RCTs and systematic reviews for osteoarthritis, with evidence for modest reductions in pain and potential structural benefits. NCCIH conditionally recommends against use for knee/hip OA but acknowledges a body of mixed clinical data.

Chrysin reduces arthritic inflammation in a complete Freund's adjuvant (CFA)-induced rat model, significantly lowering arthritis score, ESR, rheumatoid factor, and inflammatory cell infiltration, with effects comparable to piroxicam. It also attenuates NLRP3 inflammasome-driven synovitis in knee osteoarthritis models. Evidence is preclinical.

Cinnamon is documented in traditional Ayurvedic medicine for rheumatic and joint conditions, and clinical evidence from an RCT shows significant reduction of inflammatory markers CRP and TNF-α relevant to arthritis. Traditional use specifically for joint pain and rheumatism is referenced in pharmacopeial and ethnomedicinal sources.

Preclinical models consistently show CQ reduces joint swelling and inflammatory markers in arthritis models. The Bloomer 2013 open-label human study demonstrated reduced joint pain in exercise-trained men, and a separate open-label trial reported a 40% reduction in WOMAC scores in osteoarthritis patients. Animal studies show CQ extract targets cartilage degradation, bone erosion, and synovial inflammation.

CLA has demonstrated anti-inflammatory effects relevant to arthritis via inhibition of COX-2 and TNF-α. Both animal models of collagen-induced arthritis and human RA trials show reduction in inflammatory joint markers with CLA supplementation, with combination therapy (CLA+vitamin E) showing reduced morning stiffness and pain.

Clematis species have the most robust evidence base for arthritis among all its traditional indications. SKI306X (containing C. mandshurica) has been evaluated in multiple randomized controlled trials in osteoarthritis patients and showed comparable pain relief to diclofenac and was approved as a botanical drug in Korea. TCM use of Wei Ling Xian (C. chinensis/C. mandshurica) for joint pain spans over 1,000 years.

Eugenol from clove inhibits prostaglandin synthesis via COX-2 and NF-κB, mechanisms directly relevant to arthritis. Animal studies show eugenol suppresses arthritic joint inflammation and improves limb function in osteoarthritis models.

Marine oils including cod liver oil reduce inflammatory mediators implicated in arthritic joint pain and swelling. Multiple RCTs demonstrate clinically meaningful improvements in joint tenderness and stiffness. The EPA and DHA content are considered the primary active components.

Coix extract has been tested in a complete Freund's adjuvant-induced rheumatoid arthritis rat model, significantly reducing paw edema, PGE2, and MMP-3. Traditional use for arthralgia and 'dampness-obstruction' (bi syndrome) is documented in classical TCM texts.

Undenatured type II collagen (UC-II) and hydrolyzed collagen peptides have been evaluated in multiple RCTs for osteoarthritis and rheumatoid arthritis. A 2016 multicenter double-blind RCT found UC-II significantly outperformed glucosamine+chondroitin on WOMAC pain, stiffness, and function. The 2017 dietary supplements meta-analysis (69 RCTs) identified collagen hydrolysate as showing a large clinical effect size for OA pain.

Multiple RCTs demonstrate that topical comfrey root extract is effective for degenerative arthritis (osteoarthritis), particularly of the knee. A double-blind, randomised, bicenter, placebo-controlled trial (n=220) found VAS pain scores improved 54.7% in the comfrey group versus 10.7% with placebo. A 2013 Cochrane-referenced review concluded that comfrey 'probably' improves arthritis pain more than placebo.

Commiphora mukul (guggul) has clinical and extensive animal study evidence for arthritis. A clinical outcomes study found C. mukul useful for osteoarthritis of the knee; animal studies confirm anti-arthritic activity comparable to ibuprofen and phenylbutazone. Traditional use spans Ayurvedic and Chinese medicine.

β-Cryptoxanthin suppresses aggrecanase-mediated articular cartilage degradation in arthritic animal models and inhibits IL-1β-driven inflammatory cytokine expression in primary chondrocytes. Epidemiological studies associate higher BCX intake with reduced risk of inflammatory polyarthritis.

Curcumin is the primary polyphenolic curcuminoid from turmeric, shown in multiple RCTs and meta-analyses to reduce pain and improve function in knee osteoarthritis, with a large effect size in the 2017 systematic review of 69 OA supplement RCTs. It acts via NF-κB, COX-2, and 5-LOX inhibition.

Curcuminoids are the collective polyphenolic pigments in turmeric (curcumin, bisdemethoxycurcumin, demethoxycurcumin) that mediate its anti-inflammatory and anti-arthritic effects. As a group, they inhibit NF-κB, COX-2, and 5-LOX, with multiple RCTs confirming significant improvements in OA pain and function.

Blackcurrant seed oil (rich in GLA) has been tested in rheumatoid arthritis RCTs with documented reductions in joint tenderness, morning stiffness, and disease activity. GLA metabolites suppress synovial inflammation through prostaglandin E1 pathways. Traditional anti-rheumatic use of the plant is also documented.

Devil's Claw (Harpagophytum procumbens) root extract has been evaluated in multiple clinical trials and a 2016 Cochrane review, demonstrating pain-reducing effects in osteoarthritis and musculoskeletal pain greater than placebo. The Arthritis Foundation confirms that harpagoside, its active ingredient, reduces joint pain and inflammation.

DHA (docosahexaenoic acid) is a long-chain omega-3 fatty acid that reduces joint inflammation by modulating arachidonic acid metabolism and generating pro-resolving lipid mediators (resolvins, protectins). Meta-analyses of fish oil (EPA+DHA) in rheumatoid arthritis confirm reductions in joint pain, stiffness, and NSAID use. DHA also supports cartilage chondrocyte health.

DHA and EPA reduce joint inflammation in arthritis by lowering pro-inflammatory eicosanoid synthesis and pro-inflammatory cytokine production (TNF-α, IL-1β). Omega-3s including DHA are recognized for managing rheumatoid arthritis, with anti-inflammatory properties documented in systematic reviews. Clinical evidence demonstrates modest reductions in joint pain and stiffness with EPA+DHA supplementation.

Dog Rose (Rosa canina) rosehip powder has the strongest clinical evidence base of any condition in this list. Multiple RCTs and meta-analyses demonstrate moderate-quality evidence for reduction in pain and joint stiffness in osteoarthritis patients. A Cochrane-methodology systematic review (2018) of 7 RCTs (n=594) found statistically significant improvements in pain (SMD −0.28) and stiffness (SMD −0.31). Clinical use also extends to rheumatoid arthritis with preliminary evidence.

EGCG markedly reduces arthritic symptoms in the pristane-induced arthritis rat model, with effects comparable to methotrexate when administered early and continuously. It suppresses synovial inflammation, joint destruction, and cartilage damage via anti-inflammatory and anti-oxidative mechanisms relevant to both rheumatoid and osteoarthritis.

Eggshell membrane (ESM), derived from the inner membrane of hen's eggs, contains collagen, hyaluronic acid, glucosamine, and chondroitin sulfate. Multiple RCTs demonstrate that ESM supplementation (500 mg/day) reduces joint pain and stiffness in knee osteoarthritis within 10–60 days, with effects on joint mobility and strength.

EPA supplementation is among the best-supported nutritional interventions for rheumatoid arthritis. At least 13–17 RCTs show fish oil/EPA reduces tender joint count, morning stiffness, NSAID requirements, IL-1β, and TNF-α. A meta-analysis confirmed clinical benefit, and EPA-predominant formulations show superior effects in reducing arthritic markers.

E. littorale methanolic extract demonstrated significant analgesic and anti-arthritic activity in Freund's adjuvant-induced arthritis in rats, reducing paw volume and elevating antioxidant enzymes. Traditional systems (Siddha, Ayurveda) also document its use for rheumatism. Preclinical evidence is consistent with an anti-inflammatory mechanism via antioxidant pathways.

EPA (eicosapentaenoic acid) is a long-chain omega-3 fatty acid from marine sources that suppresses arachidonic acid metabolism, reducing prostaglandins and leukotrienes in arthritic joints. Meta-analyses confirm EPA supplementation reduces joint pain and morning stiffness in rheumatoid arthritis, with narrative reviews supporting a role in osteoarthritis.

Topical and inhaled eucalyptus oil has documented anti-inflammatory and analgesic effects relevant to arthritic conditions. An RCT in total knee replacement patients showed significant reductions in post-operative pain and blood pressure. 1,8-Cineole inhibits joint inflammatory mediators in preclinical models and has been used in massage formulations for arthritic joints.

In collagen-induced arthritis (CIA) rat models, multiple E. ulmoides extracts significantly reduced ankle swelling, cytokine levels, joint destruction markers (MMP-9), and RANKL/OPG imbalance. In vitro, eucommia inhibits pro-inflammatory cytokines in human immune cells including macrophages. TCM records include joint pain as a classical indication.

EPO has been investigated in rheumatoid arthritis (RA) in multiple RCTs. The 2024 systematic review found mixed results: some studies showed significant symptom improvement (joint tenderness, morning stiffness) while others found no significant impact. The mechanistic basis—GLA-mediated reduction in pro-inflammatory eicosanoids—is well established.

Fenugreek seeds and mucilage have demonstrated significant anti-arthritic effects in preclinical animal models via inhibition of NF-κB, suppression of COX/LOX pathways, and reduction of TNF-α, IL-6, paw edema, and arthritic index. Clinical trial evidence in human arthritis patients is limited; the preclinical evidence base is robust.

Fisetin reduces joint inflammation and senescent-cell-driven osteoarthritis pathology in preclinical models through NF-κB suppression and senolytic clearance of chondrocyte senescent cells. Senescent cells in joints have been directly linked to osteoarthritis in mice.

Fish oil provides EPA and DHA omega-3 fatty acids that reduce synovial inflammation by suppressing prostaglandins, leukotrienes, and pro-inflammatory cytokines. Meta-analyses confirm benefits for rheumatoid arthritis (reduced joint pain, morning stiffness, NSAID use), and narrative reviews support a role in osteoarthritis management.

Flaxseed's ALA omega-3 and lignan content have documented anti-inflammatory properties relevant to arthritis. RCTs in rheumatoid arthritis patients show mixed results: whole flaxseed (30 g/day) reduced DAS28, pain, and morning stiffness in one trial, while flaxseed oil showed limited benefit in RA compared to whole seed.

C. speciosa has long been used in TCM for rheumatic arthralgia and is listed in the Chinese Pharmacopeia for this indication. Multiple preclinical studies confirm analgesic and anti-arthritic effects via suppression of inflammatory cytokines and the MAPK pathway. The evidence base includes several rodent arthritis models and a network pharmacology/molecular docking analysis.

Geniposide from Gardenia jasminoides has demonstrated anti-arthritic effects in adjuvant-induced arthritis rat models, suppressing synoviocyte hyperpermeability via RhoA/p38MAPK/NF-κB/F-actin pathways and reducing joint inflammatory cell infiltration. Anti-osteoporosis effects relevant to bone-joint health have also been identified. Evidence is preclinical.

Garlic inhibits inflammatory pathways relevant to both osteoarthritis and rheumatoid arthritis, including COX, LOX, TNF-α, and IL-1β. Clinical data support reductions in arthritis-related pain and inflammation markers in human trials. Research suggests overweight and obese individuals with osteoarthritis may benefit from garlic supplementation.

Gentian-derived gentiopicroside has demonstrated anti-arthritic properties in preclinical models: it protected rat articular chondrocytes from IL-1β-induced inflammation, inhibiting p38, ERK, and JNK MAPK pathways and reducing matrix metalloproteinase (MMP) release while increasing collagen type II. Gentiana macrophylla extract has traditional use in Chinese, Tibetan, and Mongolian medicine for arthritis and was studied in rodent arthritis models. Evidence is animal/in vitro only.

Gentiana macrophylla is one of the most-cited TCM herbs for arthritic conditions, supported by preclinical pharmacological evidence. Iridoid glucosides from its flowers were tested in a collagen-induced arthritis rat model, and root extracts show anti-arthritic activity across multiple inflammatory animal models. It has been prescribed for arthritis, including hot and cold types, since the Shennong Bencao Jing era.

Ginger (Zingiber officinale) contains gingerols and shogaols that inhibit prostaglandin and leukotriene synthesis, with traditional use in Ayurvedic and Chinese medicine for arthritis. Several small RCTs show modest OA pain reduction; a Cochrane-cited review notes limited efficacy in OA, though traditional use is well established.

A 12-week double-blind, placebo-controlled RCT in 90 postmenopausal women with osteopenia found that 3 g/day of ginseng extract significantly improved WOMAC arthritis index scores and knee arthritis symptoms, alongside improvements in bone formation markers. Ginsenosides possess documented anti-inflammatory properties relevant to joint inflammation. Clinical evidence remains preliminary, with few dedicated arthritis RCTs.

GLA is among the best-studied natural supplements for rheumatoid arthritis, with multiple randomized controlled trials demonstrating clinically relevant reductions in joint pain, swelling, and disease activity. A key 1996 double-blind RCT (n=56) found 2.8 g/day GLA over 6 months produced significantly greater improvement than placebo. Evidence is particularly strong compared to most herbal/supplement interventions for RA.

Glucosamine is an endogenous amino monosaccharide and substrate for cartilage glycosaminoglycan synthesis. Multiple RCTs and systematic reviews have assessed its role in osteoarthritis, with conflicting but overall modestly positive evidence for pain reduction and functional improvement, particularly in knee OA. NIH/NCCIH acknowledges the evidence base as mixed.

An analysis of 41 animal and human studies including 25 clinical trials found collagen (glycine-rich) benefited osteoarthritis and aided cartilage repair regardless of dose, type, or brand. Glycine's anti-inflammatory mechanism (dampening macrophage/neutrophil activation) is directly relevant to arthritis pathophysiology. Meta-analyses confirm collagen peptide analgesia in knee OA.

Clinical studies using Phytodolor — a combination herbal product containing goldenrod, aspen bark, and ash bark — have shown efficacy comparable to standard NSAID doses for osteoarthritis and rheumatoid arthritis pain in human trials. The German Commission E and formal phytotherapy literature recognize goldenrod-containing preparations for rheumatic complaints. Isolating goldenrod's individual contribution remains difficult.

Gotu Kola has anti-inflammatory activity demonstrated in animal arthritis models for both rheumatoid and osteoarthritis. Its ability to improve peripheral circulation to joints, reduce pro-inflammatory cytokines, and modulate collagen metabolism supports its use for arthritic conditions. Traditional use for arthritis and gout in Ayurveda and TCM is extensive.

Gravel root is classified as an antirheumatic herb with pre-clinical scientific evidence supporting anti-inflammatory activity. Cistifolin inhibits integrin-mediated leukocyte adhesion in vitro, and the root extract reduced carrageenan-induced edema in rats. Traditional use for rheumatism/arthritis is also well-established.

Green chiretta has been studied in randomised controlled trials for both rheumatoid arthritis and knee osteoarthritis. RCT evidence shows significant reductions in joint pain, swelling, stiffness, and functional disability. A clinical RCT in 60 RA patients found significant improvements in tender and swollen joint counts and HAQ scores.

Green-lipped mussel (Perna canaliculus) contains unique omega-3 fatty acids, including eicosatetraenoic acid (ETA), that dually inhibit both COX and LOX inflammatory pathways. A 2021 systematic review of nine clinical trials found clinically significant reductions in OA pain, and it has been a dietary staple of New Zealand Māori populations historically associated with low joint disease rates.

Guggul and its formulations have been studied in both osteoarthritis and rheumatoid arthritis. Small clinical case studies and early trials suggest reductions in pain, stiffness, and swelling. In vitro and in vivo models confirm inhibition of inflammatory mediators relevant to joint destruction.

Harpagoside is the principal iridoid glycoside from Devil's Claw (Harpagophytum procumbens) responsible for much of its anti-inflammatory and analgesic activity. It inhibits COX-2 and modulates NF-κB and TNF-α, with clinical preparations standardized to 50–100 mg harpagoside daily demonstrating moderate evidence of benefit in osteoarthritis.

Hesperetin exerts chondroprotective and anti-inflammatory effects in osteoarthritis models, operating through the AMPK-NF-κB signaling pathway. It inhibits both IL-1β- and TNF-α-induced inflammatory responses in human chondrocytes in vitro, though direct human clinical trial data specifically in arthritis patients is currently limited to preclinical models.

Hyaluronic acid (HA) is a natural component of synovial fluid and articular cartilage, used as intra-articular injection (viscosupplementation) and increasingly as an oral supplement for osteoarthritis. Intra-articular HA has extensive RCT and meta-analysis support for knee OA pain reduction. Oral HA has emerging pilot evidence for joint pain.

Traditional use of Impatiens for rheumatism and joint pain is extensively documented across Asian and African folk medicine. Preclinical evidence from an animal model (Hariyanto et al., 2016) demonstrated antiarthritic activity of I. balsamina extract in a rheumatoid arthritis model. COX-2 inhibitory activity provides mechanistic support.

Indian Frankincense has the strongest clinical evidence base of any herbal remedy for osteoarthritis. Multiple RCTs and a meta-analysis of 7 trials (n=545) demonstrate significant reductions in pain and stiffness and improvements in joint function. Benefits have been shown to persist for up to 15 days after stopping supplementation.

Anti-arthritic activity of H. indicus is among its confirmed pharmacological properties, supported by multiple in vitro and in vivo preclinical studies. Leaf extract showed anti-arthritic activity superior to standard reference compounds in in vitro testing. Traditional Ayurvedic use for rheumatism and joint conditions is extensively documented.

Animal studies using oral PC extract showed significant reductions in TNF-alpha, IL-6, and C-reactive protein in experimentally induced arthritis, with an analgesic effect also demonstrated. Topical PC extract reduced inflammation in mouse ear models. PC is traditionally used in TCM for joint pain and osteomyelitis. Resveratrol's NF-κB and COX-2 inhibition provide mechanistic support.

Krill oil from Antarctic krill (Euphausia superba) provides omega-3 fatty acids (EPA and DHA) in phospholipid form, along with astaxanthin. The Arthritis Foundation identifies krill oil as having potential to reduce body inflammation. Preclinical OA models show cartilage protection, and it is the subject of an ongoing Australian multicenter RCT (KARAOKE trial) specifically for knee OA with synovitis.

Glycine is essential for the synthesis of type II collagen, the major structural protein in articular cartilage degraded in arthritis. It also reduces pro-inflammatory cytokine production (TNF-alpha, IL-6) and NF-κB activation, which drive synovial inflammation. Clinical trials of glycine-rich collagen peptides show improvements in joint pain and function in osteoarthritis patients.

L-methionine's downstream metabolite SAMe has been evaluated in 14 clinical trials for osteoarthritis. An AHRQ evidence synthesis (102 studies) found that SAMe showed a small-to-moderate effect vs. placebo for osteoarthritis and was not significantly different from NSAIDs. SAMe is proposed to stimulate proteoglycan synthesis in chondrocytes and exert anti-inflammatory and analgesic effects.

A randomized controlled clinical trial found that aromatherapy massage with lavender essential oil significantly reduced pain and disability in patients with knee osteoarthritis. Lavender's analgesic and anti-inflammatory properties provide a mechanistic basis for these findings. This represents targeted evidence for lavender in an arthritic joint condition.

Lemon's vitamin C and flavonoids have anti-inflammatory properties relevant to arthritis. Vitamin C deficiency is associated with joint pain and impaired collagen integrity (classic scurvy symptoms). Citrus flavonoids inhibit pro-inflammatory cytokines (IL-6, TNF-alpha) documented in arthritis pathogenesis.

D-limonene's anti-inflammatory and antinociceptive properties have been studied in the context of joint inflammation and arthritis-related pain in preclinical models. It suppresses TNF-α, IL-1β, IL-6, and COX-2 — cytokines and enzymes central to arthritic inflammation. A recent 2026 gout-related study examined limonene's hepatoprotective and anti-inflammatory properties relevant to uric acid-driven joint inflammation.

Luteolin reduces inflammatory mediators and pain behaviors in preclinical models of both rheumatoid and osteoarthritis. It targets NF-κB, COX-2, and pro-inflammatory cytokines involved in joint inflammation. Preclinical evidence is robust; human data are currently lacking.

Manganese is required for the synthesis of proteoglycans and glycosaminoglycans in cartilage, structures degraded in osteoarthritis. MnSOD activity is reduced in arthritic joints, and oxidative stress contributes to cartilage degradation. Evidence for therapeutic supplementation benefit is limited.

Mangosteen xanthones inhibit COX-1, COX-2, NF-κB, and inflammatory cytokine pathways directly relevant to arthritis pathogenesis. A review of mangosteen's anti-inflammatory potency identified arthritis and soft-tissue inflammation among the conditions supported by its xanthone activity. Evidence is primarily preclinical (in vitro and animal), with no dedicated arthritis RCTs in humans.

Topical menthol-containing gels and creams have clinical evidence for reducing pain and improving function in osteoarthritis, particularly knee OA. Menthol's TRPM8 activation and sodium channel blockade provide analgesic effects at the site of application.

Both M. officinalis and M. citrifolia extracts demonstrate anti-arthritic and analgesic effects in preclinical models, and M. citrifolia has traditional documentation for arthritis across Polynesian, Asian, and Caribbean traditional medicine. Iridoid glycosides and anthraquinones are the primary active constituents suppressing inflammation via NF-κB and MAPK pathways.

Methylsulfonylmethane (MSM) is an organosulfur compound studied in pilot and subsequent RCTs for knee osteoarthritis. A landmark 2006 placebo-controlled RCT (Kim et al.) found 6 g/day MSM over 12 weeks significantly improved WOMAC pain and function scores. A 2017 multi-RCT systematic review rated the evidence for MSM in OA as moderate.

A. vulgaris is traditionally used to treat arthritis and gout in Vietnamese medicine, and preclinical studies confirm xanthine oxidase inhibitory and anti-inflammatory activities relevant to gout. Moxibustion has been clinically studied for osteoarthritis pain. Flavonoids in mugwort suppress inflammatory cytokines implicated in joint inflammation.

Mustard plaster applied topically has documented use as a rubefacient for arthritis pain relief; a PMC study specifically evaluated Brassica juncea mustard plaster for knee pain reduction in geriatric osteoarthritis. AITC also inhibits NF-κB-mediated inflammatory pathways relevant to joint inflammation.

Cetyl myristoleate (CMO) has been evaluated in multiple human trials for various forms of arthritis, including osteoarthritis and psoriatic arthritis. A 1997 multicenter, double-blind, placebo-controlled RCT (Siemandi, n=382) found 63% of CMO-treated patients showed improvement versus 15% on placebo. A 2002 RCT of 64 patients with knee OA published in the Journal of Rheumatology found significant improvement in range of motion versus placebo. Evidence quality is limited by small sample sizes and methodological gaps, but preclinical and clinical data consistently support an anti-arthritic effect.

A double-blind RCT with an AyuFlex® standardized TC aqueous extract (250 mg or 500 mg twice daily, 84 days) in 105 overweight subjects demonstrated improved joint mobility, comfort, and functional capacity versus placebo. TC also demonstrated antiarthritic activity in preclinical models.

Myrrh's guggulsterone constituent is documented to play anti-inflammatory roles in inflammatory joint conditions including arthritis. Animal model studies confirm analgesic and anti-inflammatory efficacy. Traditional Chinese medicine has used myrrh-containing formulations (e.g., Huoluo Xiaoling Dan) for arthritis with documented clinical outcomes.

NAG has been studied specifically for osteoarthritis and cartilage metabolism. A 2016 randomized double-blind placebo-controlled trial (Tomonaga et al., Experimental and Therapeutic Medicine) in 68 healthy adults found that 500–1,000 mg/day NAG for 16 weeks shifted cartilage biomarkers toward reduced collagen breakdown. Mayo Clinic notes that clinical evidence for NAG in osteoarthritis is more limited than for glucosamine sulfate.

Stinging nettle (Urtica dioica) has been used for arthritis since at least the 10th century. Ten clinical trials for OA have been conducted; a 2000 RCT (Phytomedicine) found topical nettle leaf relieved thumb OA pain. Nettle inhibits NF-κB, myeloid dendritic cells, and TNF-α, with multiple studies showing reduced OA pain and NSAID use.

C. rotundus 70% alcohol extract has demonstrated anti-arthritic activity in formaldehyde-induced arthritis in albino rats. The PMC 2018 review lists anti-arthritic as a proven pharmacological activity. Preclinical studies show suppression of inflammation markers relevant to joint inflammation.

OA reduces synovial inflammation in osteoarthritis models by suppressing IL-1β-induced fibroblast-like synoviocyte dysfunction via the SIRT3-NF-κB axis. It inhibits COX-2, PGE2, iNOS, and matrix metalloproteinases in joint tissue. Traditional Chinese medicine also uses OA-containing plants for joint complaints.

Early clinical studies suggest that olive extract preparations may reduce pain and improve movement in osteoarthritis. Olive polyphenols exert anti-inflammatory effects in joint and periarticular tissues by suppressing NF-κB, TNF-α, IL-1β, and COX-2 pathways. Evidence remains preliminary but is grounded in human observational and early interventional data.

EVOO polyphenols, particularly oleocanthal, have well-documented anti-inflammatory mechanisms relevant to arthritis, including COX inhibition. Human epidemiological data link Mediterranean diet with EVOO to lower arthritis prevalence. In vitro studies confirm EVOO polyphenolic extracts suppress key inflammatory mediators in synovial tissue.

Omega-3 fatty acids (EPA and DHA) from marine sources reduce prostaglandin, leukotriene, and pro-inflammatory cytokine production through competitive inhibition of arachidonic acid metabolism. Meta-analyses confirm they reduce joint pain and morning stiffness in rheumatoid arthritis, and narrative reviews support a role in osteoarthritis.

GLA-rich omega-6 oils (evening primrose, borage) have RCT evidence in inflammatory arthritis, particularly RA. The mechanism involves GLA's anti-inflammatory downstream metabolites competing with AA-derived pro-inflammatory eicosanoids. Evidence for non-rheumatoid osteoarthritis is sparse. The American Family Physician and EBSCO note that preliminary evidence supports GLA use in RA with effects emerging after 1–3 months.

Quercetin from onion has demonstrated promise against arthritis symptoms in both experimental models and human clinical studies. It targets inflammatory markers relevant to osteoarthritis and may reduce side effects of conventional arthritis medications. Onion's broad anti-inflammatory activity addresses the chronic low-grade inflammation underlying arthritic conditions.

PABA has been investigated in human studies for rheumatoid arthritis, primarily in combination with cortisone or aspirin. A 1954 study in 31 patients treated for one year with PABA plus cortisone found benefit comparable to higher-dose cortisone alone. A 1953 study also reported that PABA combined with acetylsalicylic acid produced beneficial effects in active rheumatoid arthritis. Evidence is old and uncontrolled.

P. foetida has documented antiarthritic activity in preclinical studies dating to the 1960s, with more recent work confirming anti-inflammatory and disease-modifying mechanisms. It is also used in Ayurveda and multiple Indian tribal traditions for joint diseases including rheumatism. Iridoid glycosides and membrane-stabilizing components are considered responsible.

Palm tocotrienols have shown anti-arthritic activity in animal models of both rheumatoid and osteoarthritis, reducing inflammatory joint markers and cartilage destruction. The TRF from palm oil markedly reduced arthritis progression in in vivo models by blocking chronic inflammatory pathways. Human clinical trials are lacking, but preclinical evidence is substantive.

TGP (total glucosides of peony) has well-documented anti-arthritic effects and has been clinically developed in China as an approved drug for rheumatic diseases. Multiple systematic reviews of RCTs confirm TGP as effective adjunctive therapy for reducing disease activity in osteoarthritis and inflammatory arthritis.

Proteolytic enzyme/peptidase combinations (bromelain, trypsin, chymotrypsin, papain) have been evaluated in multiple clinical trials for osteoarthritis. A 2022 review of nine clinical studies and a randomized trial versus diclofenac found efficacy comparable to NSAIDs in reducing knee osteoarthritis pain. A review of ten studies (Brien et al.) found bromelain effective at reducing pain, swelling, and joint stiffness in OA.

P. amurense bark extract has been evaluated in a double-blind RCT for osteoarthritis of the knee, with NP06-1 (P. amurense + citrus extract) reducing joint pain scores (Lequesne Algofunctional Index) and inflammatory biomarkers. Phellodendron species are noted in a 2024 review as promising for osteoarthritis and osteoporosis through anti-inflammatory and cartilage-protective mechanisms. In TCM, P. amurense is traditionally used for joint inflammation and arthritis.

Multiple RCTs and a systematic review of 39 trials show Pycnogenol (pine bark extract) reduces pain, stiffness, and analgesic use in osteoarthritis patients. It also reduces biomarkers of cartilage degradation. Doses of 100–150 mg/day have been used in joint health clinical trials.

Multiple RCTs show Pycnogenol reduces pain, stiffness, and analgesic use in knee osteoarthritis. The 2018 PubMed review confirmed restored mobility in seniors with osteoarthritis. Mechanistically, Pycnogenol inhibits cartilage-degrading enzymes and reaches synovial fluid after oral administration.

Multiple RCTs and clinical reviews support bromelain's analgesic and anti-inflammatory effects in osteoarthritis. One study found bromelain comparable in efficacy to the NSAID diclofenac in hip osteoarthritis patients. Evidence for rheumatoid arthritis is more limited but exists. Doses used clinically range from 540–1890 mg/day.

A systematic review (ScienceDirect, 2025) of five clinical studies (one pilot and four RCTs) found pomegranate demonstrates anti-inflammatory, antioxidant, and chondroprotective effects in both rheumatoid arthritis (RA) and osteoarthritis (OA). Two RCTs reported significant improvements in disease activity and inflammatory biomarkers. Evidence supports use as an adjunctive—not standalone—therapy.

Prickly ash has preclinical evidence (rodent models) and traditional use for arthritis, particularly osteoarthritis. A rodent study showed Zanthoxylum extract significantly lowered markers of pain and inflammation related to osteoarthritis. The 2024 PMC review identifies arthritis as a key inflammatory disease target. Multiple monographs list it as anti-rheumatic. No human clinical trials exist.

In vivo animal studies demonstrate anti-arthritic activity of Opuntia monacantha extract via modulation of pro- and anti-inflammatory cytokines. In vitro human chondrocyte studies show reduction of key inflammatory mediators. Traditional use for joint pain is documented across multiple cultures.

B. diffusa root extract has demonstrated anti-arthritic activity in adjuvant-induced arthritis rat models, reducing joint swelling and inflammatory markers. Traditional Ayurvedic formulation Narayan Oil with punarnava is specifically used for arthritis and neuralgia. The punarnavine alkaloid and boeravinones are the primary anti-inflammatory constituents implicated.

A 2024 parallel double-blinded RCT (n=86) found purslane supplementation was safe and well-tolerated in rheumatoid arthritis patients; anti-inflammatory and antioxidant markers were the primary outcomes. Traditional use of purslane for arthritis is also well-documented across global ethnobotanical records. The omega-3 and anti-inflammatory phytochemical content provides mechanistic support.

Pycnogenol (French maritime pine bark extract, Pinus pinaster) is a standardized polyphenol mixture containing procyanidins and phenolic acids. Multiple RCTs demonstrate improvements in knee OA pain and function; a 2017 dietary supplement meta-analysis (69 RCTs) found pycnogenol had a large effect size (>0.80) for short-term OA pain reduction. The Arthritis Foundation lists it as having limited but supportive evidence for knee OA.

Queen of the meadow has pre-clinical evidence for anti-arthritic activity, with COX-1 and COX-2 inhibition demonstrated in vitro and anti-inflammatory effects confirmed in animal models. The EMA formally recognizes it as a traditional product for minor joint pain. Pharmacological evaluations have shown anti-arthritis activity, though human RCTs are absent.

A randomized, double-blind, placebo-controlled trial in 50 women with rheumatoid arthritis found that 500 mg/day quercetin for 8 weeks significantly reduced morning stiffness, pain scores, disease activity (DAS-28), and plasma TNF-α compared to placebo. Mechanistic studies show quercetin inhibits NF-κB and suppresses pro-inflammatory cytokines including IL-1β, IL-6, and TNF-α in joint tissue. Evidence for osteoarthritis is less robust, relying mainly on preclinical and animal data.

A polyphenol-enriched red raspberry extract (RRE) reduced cartilage degradation in an IL-1β-stimulated in vitro bovine explant model and significantly reduced inflammation in an adjuvant-induced arthritis rat model. The extract was standardized to anthocyanins and ellagitannins, which inhibit COX-2, NF-κB, and inflammatory cytokines. Raspberry leaf is additionally noted in herbal traditions as a cleansing diuretic included in rheumatic remedies. No human RCT data for arthritis specifically exist.

Preclinical and review-level evidence supports Rehmannia's anti-arthritic activity. In vitro and animal studies show catalpol reduces Th17 cell-driven inflammation in rheumatoid arthritis models by upregulating let-7g-5p and suppressing STAT3. A Korean literature review confirmed anti-arthritic effects among Rehmanniae Radix-studied properties. Rehmannia has also been shown to alleviate osteoarthritis pain and cartilage degradation via neuropeptide and NF-κB pathway modulation.

Resveratrol has been tested in human RCTs for knee osteoarthritis and studied mechanistically in rheumatoid arthritis cell models. The ARTHROL Phase 3 RCT (n=142, double-blind, 6 months) assessed oral resveratrol versus placebo for painful knee OA at three French tertiary centers. Preclinical and in vitro data robustly show resveratrol inhibits NF-κB and activates SIRT1 to suppress inflammatory cytokines in articular cartilage and synovial cells.

Rosehip (Rosa canina) powder has the most rigorous herbal evidence for osteoarthritis: a meta-analysis of three RCTs (n=287) found patients twice as likely to respond to rosehip versus placebo, with consistently reduced pain scores. RCTs also show benefits for hip and knee range of motion and reduced rescue medication use.

Standardized rose hip powder (Rosa canina subspecies) has been evaluated in multiple RCTs and a meta-analysis for osteoarthritis. A 2008 meta-analysis of three RCTs (287 patients, median 3 months treatment) found patients on rose hip powder were twice as likely to respond compared to placebo, with consistent pain score reductions. Active phytochemicals include GOPO (galactolipid) and vitamin C.

A 2025 double-blind RCT demonstrated that 12 weeks of oral rosemary leaf powder (4 g/day) in 72 rheumatoid arthritis patients significantly reduced disease activity scores, joint counts, pain scores, CRP, and ESR. An earlier pilot trial with a rosemary-containing combination also found significant VAS pain reductions in osteoarthritis and rheumatoid arthritis patients.

Rosmarinic acid has well-documented anti-arthritic activity in preclinical models of both osteoarthritis and rheumatoid arthritis, reducing cartilage degradation, synovial inflammation, and joint inflammatory markers. In vitro studies using T cells from rheumatoid arthritis patients showed RA induced apoptosis of activated T cells via the mitochondrial pathway.

Rutin/rutoside suppresses key inflammatory mediators (TNF-α, IL-1, IL-6, NO) from human macrophages and reduces arthritic signs in animal models. Animal studies also show rutin reduces inflammatory and neuropathic pain behaviors relevant to arthritic pain, and it inhibits COX-related prostaglandin synthesis.

Indian traditional medicine uses safflower for arthritis. Safflower's active compounds HSYA and safflomin C have demonstrated anti-arthritic and anti-inflammatory activity in preclinical models, reducing joint inflammation and pain. A comprehensive review (PMC5984022) cites anti-arthritic activity among safflower's documented pharmacological properties.

Willow bark extract (salicin) has been evaluated in multiple RCTs and a 2023 meta-analysis for arthritis pain (osteoarthritis and rheumatoid arthritis). The meta-analysis of six RCTs (n=329) found significant pain relief and improved physical status versus placebo. Individual trials produced mixed results, and evidence quality remains moderate to low.

SAMe (S-adenosyl-L-methionine) is an endogenous methyl donor studied in multiple RCTs and cited by NCCIH and PMC systematic reviews as demonstrating efficacy compared to placebo and active controls (NSAIDs) for osteoarthritis pain and function, with a favorable safety profile.

Anti-inflammatory activity relevant to arthritis has been confirmed in rat models using Smilax extracts, with documented immunomodulatory effects in adjuvant-induced arthritis. Indigenous traditions across the Americas, Mexico, and Asia have used sarsaparilla for joint pain and rheumatism for centuries. Human clinical trial data are absent.

Schizonepeta's anti-inflammatory mechanisms (NF-κB, MAPK, COX-2, TNF-α inhibition) are directly relevant to arthritis. The BMC study (2016) showed EEST protects against LPS-induced bone loss in a mouse model, with inhibition of osteoclastogenesis relevant to inflammatory arthritis. No human clinical trials for arthritis exist.

Serratiopeptidase has been studied and clinically used for both osteoarthritis and rheumatoid arthritis as an anti-inflammatory and analgesic adjunct. Clinical reviews and research summaries consistently list arthritis as an established indication. A pilot study (Klein and Kullich, 2000) examined SRP in arthritis patients. Evidence is based on small trials and is of modest quality overall.

Sesame has been studied directly in knee osteoarthritis patients. A clinical trial (50 patients, 40 g/day sesame for 2 months) found significant within-group reductions in MDA and hs-CRP. Sesamol's mechanisms include inhibition of TNF-α, IL-1β, IL-6, COX-2, and NF-κB. Evidence is preliminary but based on published human data, primarily in osteoarthritis rather than rheumatoid arthritis.

Shea nut triterpene concentrate (SheaFlex75) has been studied in a rat osteoarthritis model, demonstrating attenuation of joint destruction and OA development. Traditional use of shea butter for arthritis and joint pain is well documented across Sub-Saharan Africa. Human clinical RCTs with shea butter or its triterpene concentrate for arthritis are limited.

Z. bungeanum polyphenols have demonstrated efficacy in preclinical arthritis models, suppressing joint inflammation through NF-κB and MAPK pathway inhibition. The seed oil has also shown inhibitory effects on osteoclastogenesis relevant to bone loss in arthritis. Evidence is preclinical.

SD's anti-arthritic activity has been investigated in multiple preclinical studies using collagen-induced and adjuvant-induced arthritis animal models, demonstrating reduction in joint swelling, inflammatory cytokines, and cartilage damage. Key mechanisms involve NF-κB, MAPK, and PI3K/AKT pathway inhibition by chromone constituents. Evidence is entirely preclinical.

Rutin from S. japonica aids in suppressing oxidative stress in arthritis patients and has strong anti-inflammatory and antioxidant properties relevant to joint inflammation. S. japonica is noted in pharmacological reviews for anti-osteoporotic and anti-arthritic activities. Matrine from S. flavescens also demonstrates anti-arthritic activity in preclinical models.

Anti-arthritic activity is among the substantiated pharmacological activities of A. muricata, supported by in vivo rodent studies and longstanding traditional use of soursop fruit for rheumatism and arthritic pain across Africa and South America.

A 16-week human RCT in adults with knee osteoarthritis found that high-rosmarinic acid spearmint tea significantly reduced pain and improved stiffness and physical function scores. Standard commercial spearmint tea also improved stiffness and disability. Rosmarinic acid's COX-2 inhibition and anti-inflammatory cytokine modulation are the proposed mechanisms.

Anti-arthritic activity is among the pharmacologically confirmed activities of S. indicus in preclinical models. Carrageenan-induced paw edema studies show significant inhibition of inflammation, and the plant's anti-inflammatory constituents are mechanistically relevant to arthritis.

SPM deficiency has been documented in human synovial fluid and tissue from arthritis patients. Preclinical and human mechanistic studies demonstrate SPMs reduce joint inflammation, cartilage degradation, and arthritic pain without immunosuppression. Patients with arthritis exhibit low levels of SPMs in affected joints.

Stigmasterol has demonstrated significant anti-arthritic properties in both in vitro chondrocyte models and in vivo OA animal models, reducing cartilage degradation enzymes and inflammatory mediators. It has also been documented as having 'significant anti-arthritis effects' in peer-reviewed literature. All evidence is preclinical.

Strawberry supplementation reduced pain and key inflammatory biomarkers (IL-6, IL-1β, MMP-3, TNF-family markers) in obese adults with radiographically confirmed knee osteoarthritis in two published crossover RCTs. Constant, intermittent, and total pain scores were significantly lower in the strawberry versus control phase (p<0.05). Effects on CRP were not significant.

Beta-ecdysone derived from Pfaffia species has been shown in animal models to attenuate cartilage damage in collagenase-induced osteoarthritis via modulation of the FOXO1/ADAMTS-4/5 signaling axis. General anti-inflammatory effects of P. paniculata in animal models also support a relationship with arthritis.

Clinical trials have evaluated A. annua extract for both osteoarthritis and rheumatoid arthritis, with positive findings reported. A pilot RCT in hip/knee osteoarthritis (150 mg twice daily for 12 weeks) showed clinically meaningful pain reduction. Multiple animal and human studies support this application.

CX is used clinically in TCM settings for arthritis, and a 2022 network pharmacology and molecular docking study in Frontiers in Pharmacology mapped CX's mechanism against osteoarthritis via the MAPK pathway. Ferulic acid from CX shows anti-inflammatory efficacy against rheumatoid arthritis via NF-κB and JAK/STAT modulation. Traditional use for rheumatic and joint pain is well-documented.

Multiple preclinical studies have examined teasel root (Dipsacus asper) in arthritis models, showing inhibition of chondrocyte apoptosis, cartilage protection, and anti-arthritic gene expression changes. The herb is listed in the Korean and Chinese Pharmacopoeias as an analgesic and anti-inflammatory for arthritis. No human RCTs have been conducted.

T. chebula has documented anti-arthritic activity in both pre-clinical and clinical settings. A randomized, double-blind, placebo-controlled trial found T. chebula extract (AyuFlex) at 250 mg and 500 mg twice daily significantly reduced pain and joint discomfort versus placebo. The fruit has been used in traditional Asian medicine for arthritic diseases for over a thousand years.

THIAA has been studied in both osteoarthritis and rheumatoid arthritis contexts. In preclinical models it inhibits NF-κB, MMP-9, and TNF-α and attenuates joint swelling. A 12-week open-label case series used 150 mg nTHIAA with undenatured type II collagen in patients with chronic joint pain from OA and RA. Taylor & Francis references THIAA for inhibition of NF-κB, TNF-α, and MMP-9 relevant to osteoarthritis.

T. cordifolia inhibits arthritic inflammation and joint damage in validated animal models via suppression of pro-inflammatory cytokines (TNF-α, IL-1β, IL-6, IL-17) and shifting bone remodeling in favor of anti-osteoclastic activity. It is a traditional Ayurvedic remedy for arthritis and related musculoskeletal disorders.

Multiple rodent and in vitro studies show pterostilbene protects chondrocytes from IL-1β-induced inflammation and ROS via Nrf2 and PI3K/AKT/NF-κB pathways, reducing cartilage degeneration in surgically induced OA models. No human arthritis trials have been published.

Triphala demonstrates anti-arthritic effects in animal models through NF-κB and COX-2 inhibition, reduction of lipid peroxidation, and restoration of antioxidant levels in arthritic tissue. Terminalia chebula inhibits hyaluronidase and collagenase to prevent cartilage degradation. A pilot study on Triphala Guggulu in osteoarthritis patients showed improvement in pain and functional scores.

Multiple randomized controlled trials and a systematic review support oral enzyme combinations containing trypsin as comparable to diclofenac (NSAID) for pain and function in knee osteoarthritis. A 2025 crossover RCT also demonstrated reductions in systemic inflammation and cartilage turnover markers. Evidence is for combination products (trypsin + bromelain + rutoside).

Turmeric (Curcuma longa) rhizome contains curcuminoids, particularly curcumin, which inhibit NF-κB and COX-2 inflammatory pathways. Multiple RCTs and systematic reviews demonstrate consistent improvements in knee OA pain, stiffness, and function compared to placebo, with effects comparable to NSAIDs in some trials.

Multiple preclinical and in vitro studies show UA reduces osteoarthritis pathology by improving mitochondrial health in chondrocytes, reducing cartilage degeneration, and suppressing synovial inflammation. UA also attenuates rheumatoid arthritis symptoms in CIA mouse models by inhibiting NF-κB-driven inflammation and pyroptosis. No dedicated human arthritis RCTs have yet been completed.

A 12-week double-blind placebo-controlled RCT in 72 osteoarthritis patients found that niacinamide (3000 mg/day) improved global arthritis impact by 29% versus a 10% worsening in the placebo group (p=0.04), increased joint mobility by 4.5 degrees, reduced ESR by 22%, and allowed a 13% reduction in anti-inflammatory drug use. Observational data also associate higher niacin intake with lower prevalence of rheumatoid arthritis.

Vitamin D plays a role in bone metabolism, immune regulation, and chondrocyte function relevant to arthritis. Vitamin D deficiency is associated with increased OA and RA severity. RCTs assessing vitamin D supplementation in arthritis show variable results, but the Arthritis Foundation includes it among studied supplements, and NCCIH references its role in bone health and immune regulation in arthritis contexts.

Vitamin D3 (cholecalciferol) is the most bioavailable form of vitamin D, with a recognized role in bone health, chondrocyte regulation, and immune modulation relevant to OA and RA. The Arthritis Foundation lists it as studied for OA; NCCIH cites its role in bone health and immune regulation in arthritis. A 2018 meta-analysis found vitamin D3 supplementation reduced RA disease activity scores.

Wasabi's 6-MSITC potently suppresses COX-2, iNOS, and pro-inflammatory cytokines that drive arthritic joint inflammation, and blocks NF-κB signaling. In the rat metabolic syndrome model, wasabi attenuated acute inflammation in the heart tissue. These anti-inflammatory mechanisms are directly applicable to articular inflammation, and wasabi has traditional use for joint pain in Japanese medicine.

White willow (Salix alba) bark contains salicin, the precursor to salicylic acid, providing analgesic and anti-inflammatory effects relevant to arthritis. A 2009 systematic review of herbal medicines for OA found two RCTs of willow bark with disparate results. It has been used since antiquity for pain and inflammation, with the European Medicines Agency recognizing traditional use.

A 2023 meta-analysis of RCTs (PMC10607963; 5 studies, 6 RCTs, 329 patients with arthritis) found significant differences in pain relief and improved physical status for arthritis patients treated with willow bark vs. placebo. A landmark 6-week double-blind RCT (Biegert et al., J Rheumatol 2004; n=127 OA patients) showed WOMAC pain scores decreased 17% with willow bark vs. 10% with placebo. The EMA's HMPC recognizes willow bark for relief of minor joint pain on the basis of long-standing use.

Topical methyl salicylate is a long-established OTC treatment for arthritis pain, FDA-approved for this indication. In vitro and animal evidence shows COX-2 inhibition by gaultherin (wintergreen's salicylate glycoside). An RCT showed 30% methyl salicylate cream significantly reduced pain in knee osteoarthritis patients. Traditional use of wintergreen for rheumatism predates modern pharmacology.

Yucca has the strongest human evidence of any of its indicated uses for arthritis. A double-blind, placebo-controlled trial (Bingham et al., 1975, J Appl Nutr) found that yucca saponin tablets reduced pain, swelling, and stiffness in both osteoarthritis and rheumatoid arthritis patients. Active constituents include steroidal saponins and polyphenolics (resveratrol, yuccaols A–E) that inhibit NFκB and iNOS, suppressing nitric oxide-driven inflammation. Native American traditional use of yucca for joint pain predates these clinical findings.

Rheumatism is listed among traditional indications for A. spectabilis in Himalayan ethnobotany, and preclinical in vivo anti-inflammatory activity supports this use. The plant's COX-inhibitory and TNF-α suppressive properties are mechanistically relevant to joint inflammation.

Agrimony is traditionally used for rheumatism and joint inflammation in European folk medicine. Its anti-inflammatory properties are preclinically validated in vitro and in carrageenan-induced oedema animal models. No clinical trial in arthritis has been conducted.

Alfalfa has a long traditional use for arthritis in Ayurvedic medicine, early American herbalism, and traditional Chinese medicine, attributed to its anti-inflammatory and alkalizing properties. RxList lists osteoarthritis and rheumatoid arthritis as traditional indications. Scientific clinical evidence is lacking.

Allspice has a long traditional use for arthritis and rheumatism in Caribbean, Central American, and Ayurvedic traditions. Eugenol-based COX inhibition and β-caryophyllene's CB2 receptor activity provide mechanistic plausibility. Preclinical animal data support anti-inflammatory effects. No human arthritis trials exist.

Baltic amber has been used traditionally for joint and muscle pain, including arthritis, attributed to its analgesic and anti-inflammatory properties via succinic acid and terpenoid content. It has a history of use in European folk medicine for this purpose. No human clinical trials exist.

Anemarrhena is a named component of Guizhi Shaoyao Zhimu decoction — a classical TCM formula specifically designed for arthritis/joint bi syndrome — and traditional texts document its use for arthralgia. Sarsasapogenin's anti-arthritic properties in preclinical RA models provide mechanistic support.

Anti-inflammatory preparations of annatto are used in traditional Latin American medicine for joint pain and inflammation. Bixin and tocotrienols from annatto have demonstrated potent inhibition of pro-inflammatory cytokines (TNF-α, IL-1β, IL-6) in preclinical and human studies relevant to arthritis pathophysiology. No human clinical trials for arthritis specifically have been conducted.

Asparagus root has traditional use across European, Chinese, and Unani medical systems for rheumatism and joint pain. Decoctions of rhizomes and roots have been used in Eastern Europe and Asia for rheumatism. Anti-inflammatory phytochemicals (saponins, flavonoids) provide biological plausibility but human clinical trial evidence for arthritis is absent.

Atractylodes lancea (Cang Zhu) is specifically documented in TCM for wind-cold-damp arthralgia (Bi syndrome), and Atractylodes macrocephala appears in classical anti-arthritis formulas. Both species have anti-inflammatory preclinical data. Atractylodes was used for rheumatic diseases in Shennong's Materia Medica.

Bamboo preparations are used in Ayurvedic, Siddha, Unani, and TCM medicine for joint pain and inflammatory conditions resembling arthritis. Bamboo flavonoids inhibit NF-κB and COX-1/COX-2, the same pathways targeted by anti-arthritic drugs. In vitro and animal evidence supports anti-inflammatory effects, though no human arthritis RCT exists for bamboo.

Basil is documented in traditional medicine for arthritis and joint inflammation. The Tandfonline pharmacological review lists arthritis among traditional indications. COX and LOX inhibition by basil's fixed oil provides mechanistic plausibility for anti-arthritic effects, supported by animal models but not human trials.

Classical Ayurvedic combinations containing T. bellirica have been used for rheumatic diseases and arthritis. Traditional texts document seed oil of T. bellirica in rheumatism. The in vitro anti-inflammatory evidence (TNF-α suppression, LOX-1 inhibition, lipoxygenase inhibition) provides mechanistic support. Traditional use across Ayurveda, Unani, and traditional Chinese medicine for rheumatism is well-documented.

Birch leaf is indicated by the ESCOP monograph and German Commission E as an adjunct treatment for rheumatism and arthritis, attributed to its anti-inflammatory and uric acid-eliminating diuretic actions. Traditional use for arthritic conditions is documented across European herbal traditions. Betulin and betulinic acid have demonstrated anti-inflammatory activity in preclinical models.

Black cohosh has a long traditional use for arthritis and rheumatic conditions documented by Native Americans and 19th-century American physicians. Some limited clinical evidence exists from a combination-herb product. The herb is attributed anti-inflammatory properties partly due to salicylic acid content.

Black spruce is listed in aromatherapy references for arthritis, rheumatism, and joint pain. Its constituents bornyl acetate and α-pinene have published anti-inflammatory and chondroprotective activity in cell and animal models relevant to arthritic conditions. The British Herbal Pharmacopoeia and aromatherapy tradition support this use.

Bladderwrack has been traditionally used both internally and as a topical compress for joint pain and arthritis, attributed to its fucoidan and alginic acid anti-inflammatory content. Animal models show fucoidan reduces joint swelling and inflammatory cytokines. Human clinical trials for arthritis are lacking.

Blessed thistle was historically used as a remedy for arthritis, gout, and rheumatism in European folk medicine. This use is recorded in traditional herbal texts and pharmacopoeias. There is no pharmacological or clinical trial evidence specifically investigating blessed thistle for arthritis.

Boneset was historically used by European settlers and Eclectic physicians for sub-acute and chronic rheumatic conditions and arthritis. A 19th-century medical report (Lockwood, 1847, now archived in PMC) specifically listed 'sub-acute and chronic rheumatic affections' among indications. The in vitro anti-inflammatory data for E. perfoliatum extracts lends biological plausibility, but no clinical trials for arthritis exist.

Rheumatism and arthritis are well-documented traditional uses of buchu by the Khoisan and subsequently by Dutch Afrikaner settlers. Preclinical in vitro data show COX-1/COX-2 and 5-LOX inhibitory activity consistent with an antirheumatic mechanism. No human trials for arthritis have been performed.

C. crista is traditionally used in Ayurveda and in Indonesian and Indian ethnomedicine for rheumatism and arthritis. Decoction of root is used in Indonesia as a tonic for rheumatism. The plant's anti-inflammatory activity in preclinical models provides indirect scientific support.

Cajuput oil is documented across multiple traditional systems — Malay, Indonesian, Burmese, and Ayurvedic — as a topical remedy for arthritis and rheumatism. It is an ingredient in Tiger Balm, widely used for arthritic pain. Its anti-inflammatory and analgesic (counter-irritant) mechanisms are pharmacologically grounded. No specific clinical trials for cajuput in arthritis exist.

Celery has been used in Western and Eastern traditional medicine for arthritis and gout for centuries, with 19th-century clinical anecdotes and long-standing use in Ayurveda and TCM. Preclinical rodent studies show celery seed extract suppresses uric acid levels and joint swelling in gout models, but human RCT data are lacking.

Chickweed has documented traditional use in European and homeopathic medicine for relieving rheumatic and arthritic joint pain. One preliminary clinical study evaluated its anti-inflammatory action in polyarticular inflammatory arthritis. Animal models also show anti-inflammatory analgesic effects.

Cowage seed has documented traditional use for arthritis in Ayurveda and African traditional medicine. Several experimental studies report efficacy of M. pruriens seed extract against rheumatoid arthritis in preclinical models. No human clinical trial for arthritis has been published.

Dandelion has been used across multiple traditional medicine systems—European, Chinese, and Arabian—for arthritic and rheumatic conditions, including gout. The German physician Leonhard Fuchs (1543) documented its use for gout. Its anti-inflammatory and purported diuretic/uricosuric properties provide pharmacological plausibility, but no clinical arthritis trials exist.

Wild yam (Dioscorea villosa) has a strong documented history of traditional use for arthritis and joint inflammation. In vitro and animal studies support anti-inflammatory mechanisms. Human clinical evidence is limited to traditional practice and preliminary findings.

Jamaican dogwood has documented traditional use for inflammatory rheumatism and arthritis pain, applied both topically and internally. Animal studies confirm anti-inflammatory effects of bark extracts. Cornus officinalis has preclinical anti-inflammatory evidence. No human clinical trials for arthritis exist for any dogwood species.

Chinese herbalists have prescribed Dong Quai for arthritic joint complaints since ancient times, and it is listed in naturopathic references for arthritis. Preclinical evidence shows that A. sinensis modulates inflammation induced by monosodium urate crystals with dramatic reduction in neutrophilic infiltration, suggesting relevance to gouty and other inflammatory arthritis. No dedicated human clinical trials for arthritis have been published.

Ayurvedic medicine uses elecampane (Inula helenium) for rheumatism and joint pain, and its anti-rheumatic properties are noted across traditional systems. In vitro anti-inflammatory evidence provides mechanistic plausibility. No clinical trials have examined elecampane for arthritis.

Elderberry has documented traditional use for rheumatism and joint inflammation in European folk medicine. External preparations of leaves and bark were applied for joint swelling and arthritis-like conditions. Preclinical anti-inflammatory data provide mechanistic support, but no human clinical trials specifically address arthritis.

Feverfew has been widely used in traditional European medicine for arthritis and joint pain. The PMC systematic review and MSK monograph both record this use. Limited clinical data have not confirmed benefit, but mechanistic in vitro and animal studies support anti-arthritic activity.

European balneotherapy using peat rich in humic and fulvic acids has centuries of traditional use for rheumatic and joint diseases. In vitro studies show humic substances reduce joint inflammation and bond to collagen fibers to aid tendon repair, but dedicated human RCTs for arthritis are absent.

Traditional Asian medicine has used Ganoderma lucidum to treat arthritis for centuries. A 2025 meta-analysis of RCTs included rheumatoid arthritis as a subgroup condition, and the 2025 triterpene systematic review noted anti-inflammatory mechanisms relevant to joint inflammation.

Garlic is documented across traditional medical systems (Ayurveda, Arabian medicine) as a remedy for joint pain, rheumatism, and arthritis. Modern anti-inflammatory mechanisms—NF-κB inhibition and pro-inflammatory cytokine reduction—offer biological plausibility. Clinical RCT evidence specifically for osteoarthritis or rheumatoid arthritis joints is limited.

WebMD notes Indian gooseberry is used for osteoarthritis in traditional medicine. Amla's anti-inflammatory activity via CRP reduction and NF-κB suppression is documented in clinical trials, but arthritis-specific human trials are lacking.

GMT has documented traditional use in treating rheumatic disorders and arthritis throughout the Balkan Peninsula. Its anti-inflammatory activity in preclinical models (comparable to indomethacin) provides pharmacological plausibility, and modern preparations are described as anti-rheumatic in ethnobotanical surveys. No RCT in arthritic patients has been conducted.

Guarana has been traditionally used for arthritis and rheumatism by Amazonian indigenous peoples and in Peruvian folk medicine. The use is supported by documented ethnobotanical records, with plausible anti-inflammatory mechanisms from its polyphenol and methylxanthine content, though no clinical trials in arthritic populations have been published.

Gymnema sylvestre has well-documented traditional use in Ayurveda for arthritis, rheumatism, and joint disorders. Animal studies show anti-inflammatory effects relevant to arthritis, including reduced paw swelling. Dedicated human clinical trials in arthritic patients are absent.

H. spicatum is traditionally used in Ayurveda and folk medicine for joint discomfort and rheumatic conditions. Multiple reviews note its use for rheumatic discomfort and swelling. Preclinical anti-inflammatory studies in carrageenan models and the identification of prostaglandin/cytokine-suppressing diterpenoids provide pharmacological support, though no arthritis-specific clinical or animal studies exist.

H. antidysenterica is cited in modern Ayurvedic practice and ethnomedicine for rheumatism and arthritis, and its anti-inflammatory alkaloids have been documented in animal pain models. Seeds are used in some traditions for arthritis. No dedicated arthritis clinical trials in humans have been conducted.

Joint pain and rheumatism are among the most consistently documented traditional indications for I. aquifolium leaves, both internally as infusions and externally as poultices. The anti-inflammatory triterpenoids present in the plant provide a plausible mechanism, though human clinical evidence is absent.

Honeysuckle stems (Ren Dong Teng) are specifically used in TCM for arthritis caused by wind-dampness, and modern clinical practice in China lists arthritis among the indications for honeysuckle. Its anti-inflammatory and antinociceptive properties provide mechanistic support, though human RCT evidence is lacking.

Horse chestnut has a well-documented traditional use for arthritis and rheumatism across multiple historical traditions. The NCCIH and Drugs.com confirm this as a traditional indication. The leaf especially was employed by herbalists for arthritis-related pain and inflammation, but no clinical trials have evaluated HCSE specifically for arthritis.

Horseradish has been used topically as a rubefacient for arthritic joints for centuries. The German Commission E approves external horseradish preparations (2% mustard oil) for application to swollen and painful joints. The pungent oils increase local blood flow and provide counter-irritant analgesic effects. No RCTs have evaluated horseradish for arthritis endpoints.

Horsetail has a documented traditional use in osteoarthritis and rheumatic joint conditions across European and North American herbal traditions. Its silica content is proposed to support cartilage repair and joint connective tissue, while its anti-inflammatory flavonoids may reduce joint inflammation. Some preclinical evidence supports anti-inflammatory and antinociceptive activity, but no dedicated human clinical trials in arthritis exist.

Hydrangea root is listed in TCM and Western herbalism for joint conditions including rheumatoid arthritis and general joint pain, attributed to its anti-inflammatory properties. The halofuginone/Th17 research (from related species Dichroa febrifuga) provides preclinical scientific context for RA specifically, but general arthritis use is primarily traditional. No human arthritis trials have been conducted using hydrangea.

H. italicum is traditionally used for joint inflammation and is cited in Mediterranean folk medicine for joint pain. Biological plausibility is supported by potent in vitro and in vivo inhibition of COX, LOX, and NF-κB pathways central to arthritic inflammation, but no human clinical trials on arthritic patients are available.

Aegle marmelos is listed as having anti-arthritis activity in multiple pharmacological reviews, and traditional Ayurvedic texts describe use of bael for swollen joints, rheumatism, and musculoskeletal pain. Preclinical anti-inflammatory evidence provides a mechanistic rationale, but dedicated arthritis studies are limited.

Acacia nilotica has traditional use for painful joints and arthritis across multiple cultures. Boiled leaf extract is used for joint pain in traditional African medicine. Animal pharmacology confirms anti-inflammatory and analgesic effects relevant to arthritic conditions.

T. cordifolia has a long traditional history of use for joint pain and arthritis in Ayurveda, Siddha, and folk medicine across South and Southeast Asia. Preclinical data support anti-inflammatory and anti-arthritic activity. It is listed in ethnopharmacological compendiums as commonly used in combination with other herbs for gout and rheumatoid arthritis; controlled human trials for arthritis as a primary endpoint are not available.

Indigo (I. tinctoria) is listed in Ayurvedic materia medica for arthritis and lumbago, and anti-arthritic activity has been demonstrated in animal studies of the Indigofera genus. The anti-inflammatory alkaloids indirubin and tryptanthrin provide mechanistic plausibility. No human clinical trials exist for arthritis per se.

Kava is listed in traditional Pacific and historical Western herbal sources for rheumatism and joint inflammation, attributed to its anti-inflammatory, analgesic, and muscle-relaxant properties. Kavain-derived compounds have demonstrated anti-arthritic effects in murine models via TNF-α suppression and COX inhibition. No human clinical trial exists for arthritis.

Lemongrass is used in folk medicine for rheumatic complaints and joint pain across multiple traditions. Its anti-inflammatory and analgesic properties, demonstrated in preclinical studies, provide mechanistic support. C. citratus is classified as antirheumatic in pharmacological reviews. Human clinical trials for arthritis are absent.

Licorice root has a traditional application in arthritis management within Ayurvedic and Chinese medicine, supported by its well-characterized anti-inflammatory and corticosteroid-like mechanisms. Glycyrrhetinic acid's inhibition of inflammatory pathways (COX, NF-κB, TNF-α) provides a plausible pharmacological rationale. Dedicated clinical trials specifically for arthritis endpoints are absent in the published literature.

Multiple European ethnopharmacological traditions document S. vulgaris preparations used topically and internally for joint pain, rheumatism, and muscle aches. Syringa species are also documented in Chinese traditional medicine for arthritis-related conditions. Preclinical anti-inflammatory data provide some mechanistic support.

Eclectic physicians used lobelia liniments and tinctures topically and internally for rheumatic (arthritic) joint pain. Drugs.com historical records note lobelia was used in "treating colic, rheumatism, fever, and asthma." Felter's text describes oil of lobelia in liniments for "severe neuralgic and rheumatic complaints."

A. vasica is documented in Ayurvedic, Unani, and folk medicine for arthritis and rheumatic conditions. Traditional leaf poultices are applied to joints for rheumatic symptoms. Multiple ethnopharmacological reviews confirm antiarthritis as a recognized property.

Maqui was traditionally used by the Mapuche to treat joint pain and inflammation, with its leaves and fruit applied both topically and orally. Modern preclinical evidence supports anti-inflammatory activity through suppression of TNF-α, IL-6, and NF-κB pathways relevant to arthritic inflammation. No human clinical trial for arthritis exists.

Marjoram is documented in Moroccan folk medicine and Ayurvedic tradition for rheumatism and joint pain. Its anti-inflammatory and analgesic properties provide a pharmacological basis, and modern herbal medicine uses it for swollen joints.

Milkweed was used by Indigenous peoples and in early American herbal medicine for rheumatism and arthritis-like joint complaints. Cooked stems were applied as poultices to inflamed joints, and root decoctions were taken internally. This use is recorded in multiple ethnobotanical sources. No clinical trials have evaluated this application.

Momordica charantia is documented in traditional medicine across Asia and Africa for rheumatism and joint-related complaints. Preclinical anti-inflammatory evidence supports plausibility. No human clinical trials have directly evaluated it for arthritis.

Muira puama is traditionally used for rheumatism and joint pain across Amazonian, European, British, and German herbal medicine traditions. It is listed in the British Herbal Pharmacopoeia and employed in Germany specifically for rheumatism. Both oral and topical uses are documented. No clinical trial evidence exists for this indication.

Mulberry twig (Sang Zhi) is specifically documented in TCM for joint pain, stiffness, numbness, and swelling, with particular affinity for the shoulders and upper limbs. This is a formal indication in the Chinese Pharmacopoeia. Preclinical anti-inflammatory evidence supports the traditional use.

Mullein has been used in folk medicine for rheumatic joint pain and arthrosis across Spanish, Turkish, and Appalachian traditions. A 2021 PMC review confirmed that quercetin in Verbascum species molecularly targets inflammatory pathways relevant to arthrosis. A 2024 rat study found kaempferol (a mullein flavonoid) reduced cartilage damage and joint pain.

Neem is used in Ayurveda and Unani medicine for joint pain and arthritis, listed among traditional uses in the Indian Journal of Dermatology. The ScienceDirect overview lists antiarthritic activity of neem seed oil among documented properties. Anti-inflammatory mechanisms (COX/LOX inhibition) provide plausibility. Human RCTs for arthritis specifically are absent.

Oregano is documented in traditional medicine systems — including Balkan and Middle Eastern traditions — as a remedy for rheumatic and joint pain, applied as a liniment or taken internally. Carvacrol's COX-2 inhibitory and NF-κB suppressing activity provides a mechanistic basis for anti-inflammatory effects relevant to arthritis. No human clinical trials for arthritis outcomes have been published.

Oregon grape root tea was traditionally used by indigenous North Americans for arthritis and rheumatism. Berberine from related Berberis species demonstrates anti-arthritic activity in animal models, inhibiting inflammatory mediators relevant to rheumatoid arthritis. Human clinical trials for Oregon grape in arthritis are absent.

P. orientalis stems are traditionally used in Asian medicine for rheumatism and joint pain. Multiple ethnopharmacological sources list arthritis/rheumatism as a traditional indication. Preclinical anti-inflammatory studies provide mechanistic support.

People with inflammatory diseases including arthritis have reported symptom relief after papain ingestion in observational contexts. Proteolytic enzymes such as papain are proposed to dissolve pathogenic immune complexes relevant to arthritis. However, no controlled human clinical trials of papain specifically for arthritis have been identified in the literature.

Parsley is listed as antirheumatic in ethnopharmacological reviews, and its flavonoids (apigenin, kaempferol, luteolin) inhibit pro-inflammatory mediators relevant to arthritis. The gout-related uric acid-lowering effect via xanthine oxidase inhibition is supported by animal data.

Feverfew has a well-documented traditional role in treating arthritis across Greek, European, and folk medicine traditions, applied for joint pain and inflammation. This use is cited across multiple authoritative herbal medicine monographs. Clinical RCT evidence for general arthritis remains absent beyond the single RA trial.

Pennycress is classified as antirheumatic in traditional European medicine and was used for rheumatism and joint stiffness. Himalayan folk medicine used dried seed powder to relieve joint stiffness, and the seeds are noted as a remedy in rheumatic diseases including osteoarthritis and arthritis.

Plantago lanceolata has traditional use in rheumatism and arthritis, documented in European ethnobotany. Crushed P. lanceolata leaves mixed with salt were traditionally used to treat arthritis. Anti-inflammatory constituents (aucubin, baicalein, ursolic acid, oleanolic acid) are mechanistically relevant to joint inflammation.

Plantago lanceolata leaves have been traditionally used for arthritis and joint inflammation. Anti-inflammatory mechanisms (COX-1/COX-2 inhibition, NF-κB suppression, histamine inhibition) provide relevant pharmacological rationale. Traditional use for rheumatism and arthritis is documented globally. No dedicated human RCT for arthritis with Plantago has been published.

Rheumatic bone pain and joint discomfort are documented traditional TCM indications for Ligustrum lucidum. Anti-inflammatory and anti-osteoporotic preclinical findings provide some mechanistic support. No clinical trials for arthritis endpoints exist.

Traditional Ayurvedic and ethnobotanical sources document P. marsupium's use for arthritis, attributed to its anti-inflammatory and analgesic properties. COX-2 inhibitory activity has been noted in preclinical pharmacology reviews.

Arthritis and joint pain are consistently documented traditional uses of red clover across European, Asian, and North American herbal medicine. Multiple monographs list arthritis as a traditional indication. Isoflavone anti-inflammatory mechanisms provide plausible rationale, but no clinical trial evidence specific to arthritis has been identified.

Rehmannia has been used in TCM for joint diseases and arthritis for centuries. Clinical reports from China describe patients with rheumatoid arthritis experiencing reduced joint pain, swelling, and improved movement. Anti-inflammatory mechanisms provide a plausible biological basis.

R. cordifolia is documented across multiple traditional systems—Korean, Indian (Ayurveda), Chinese (TCM), and Unani—as a traditional remedy for arthritis and rheumatism. In traditional Asian medicine, it has been used clinically for arthritis, and one preclinical study documented anti-arthritic properties in an animal model. Limited mechanistic studies suggest COX-2 inhibition as a relevant pathway.

Sage has documented traditional use for rheumatic joint conditions and arthritis across multiple folk medicine systems. Preclinical data support anti-inflammatory and antinociceptive mechanisms. No human clinical trials specifically evaluating sage for arthritis were identified.

Use for rheumatism and arthritis is recorded across Asian traditional systems for Scrophularia root for more than two thousand years. S. buergeriana demonstrated bone disorder prevention and anti-rheumatic activity in in vitro and in vivo models. European figwort is used in baths to lessen rheumatic pains. No human clinical RCTs have been conducted.

Rheumatism and rheumatic conditions are listed among the traditional indications for Albizia species in multiple pharmacological ethnobotanical records. Anti-inflammatory properties of A. julibrissin constituents provide biological plausibility, but no arthritis-specific preclinical or clinical study has been published.

S. baicalensis has been used in TCM for arthritis and osteoarthritis. Its anti-inflammatory constituents (baicalin, baicalein) inhibit NF-κB, COX-2, and pro-inflammatory cytokines relevant to joint inflammation. Darwin-Nutrition notes EFSA-recognized use for 'arthritis and osteoarthritis.' Animal studies show benefit in arthritic models.

Joint pain and arthritis are among the traditional indications for smartweed, with the plant used as an anti-rheumatic and anti-inflammatory agent in folk medicine across Asia and Europe. Preclinical anti-inflammatory data provide mechanistic plausibility.

Sarsaparilla has been used for centuries across indigenous Central/South American, Asian, and European herbal traditions to treat joint pain and rheumatism. Animal model studies support anti-inflammatory and anti-arthritic mechanisms, but no controlled human clinical trials confirm efficacy for arthritis specifically.

Solomon's seal is used across Western herbalism, TCM, and Ayurveda for arthritic joint pain. In vitro data show P. sibiricum extracts inhibit inflammatory markers (nitric oxide, TNF-α, interleukins) relevant to arthritis pathways, but no human trial exists. The traditional application is well-documented.

Spruce resin, bark decoctions, and needle oil have extensive documented use in traditional medicine for rheumatism and joint pain across Native North American and European cultures. Resin poultices on rheumatic joints and steam baths from spruce bark are well-described ethnobotanically. The anti-inflammatory phytochemistry of spruce provides mechanistic plausibility.

Stillingia was used by Eclectic physicians for chronic rheumatism and periosteal joint pain, and is listed in traditional materia medica for rheumatism. The indication was primarily for chronic, not acute, rheumatic conditions. No clinical research exists.

Traditional herbalism uses sunflower root decoctions as warm washes for rheumatic aches and pains. Sunflower seed oil's anti-inflammatory properties (reducing TNF-alpha and pro-inflammatory cytokines) provide mechanistic plausibility for arthritis. Kouroshfoods references sunflower seeds as particularly beneficial for arthritis sufferers due to their anti-inflammatory antioxidant content.

A. calamus is used in Ayurveda and multiple traditional systems for rheumatism and arthritis, attributed to its anti-inflammatory and analgesic properties. Preclinical anti-inflammatory data support this use. Traditional references include use in rheumatoid arthritis, neuralgia, and joint pain, but no dedicated arthritis human trials exist.

Tylophora is traditionally used in Ayurveda and folk medicine for rheumatism and arthritis, with the plant's leaves and roots applied as poultices for arthritic joints in regional Indian practice. Preclinical studies show the flavone fraction of T. indica inhibits adjuvant-induced arthritis in animal models, and the alkaloid tylophorine reduces paw edema. No controlled human trials for arthritis have been published.

Watercress is documented as a traditional remedy for arthritis and rheumatic pain across Iranian, Moroccan, Turkish, and European folk medicine traditions. The 2025 systematic review of RCTs notes arthritis among traditional indications. Topical application for arthritis is also mentioned in WebMD. No clinical RCT for arthritis-specific endpoints exists.

Wheatgrass is documented in traditional and naturopathic medicine for arthritis, particularly rheumatoid arthritis, citing anti-inflammatory properties. A ScienceDirect review states that several clinical studies have shown wheatgrass extracts useful in reducing rheumatoid arthritis symptom severity. Human evidence details remain limited.

White oak bark tea is used in traditional herbalism for arthritis, valued for its anti-inflammatory and analgesic properties. Multiple traditional sources document its use for joint pain and inflammation. No clinical trials in arthritis patients have been conducted.

Wild yam has a strong traditional identity as 'rheumatism root' and was historically used for arthritis and joint inflammation. Animal studies and in vitro data show diosgenin and dioscin exert anti-inflammatory and antinociceptive effects relevant to arthritis. Human clinical trials specifically for arthritis are lacking.

Wood betony has been used in traditional European herbalism for arthritis symptoms since the Renaissance, when betony was an ingredient in Pistoia powder, an old remedy for arthritis and gout. In vitro anti-inflammatory activity provides a potential mechanistic basis.

Rheumatism and arthritis are among the oldest documented traditional uses of X. strumarium, appearing in ShenNong BenCaoJing and Mingyi Bielu. The herb is classified in TCM as a wind-damp-dispersing agent suitable for joint pain and arthralgia. Preclinical anti-inflammatory and analgesic data support the mechanism, though no specific arthritis human trial data exist.

Yarrow is traditionally used for rheumatic pain and joint inflammation across Persian and European folk medicine. Its anti-inflammatory (COX inhibition, PGE2 suppression) and analgesic pharmacology provides a plausible mechanism, though no human clinical trials on arthritis endpoints exist.

Rheumatism and arthralgia are among the most consistently documented traditional indications for Zanthoxylum species across Asia and Africa. Multiple species are used in TCM for rheumatic joint pain. Preclinical anti-inflammatory and analgesic evidence supports the mechanistic basis, but human arthritis trials are absent.